KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Gross Margin (2016 - 2025)

Globus Medical's Gross Margin history spans 15 years, with the latest figure at 68.41% for Q4 2025.

  • For Q4 2025, Gross Margin rose 848.0% year-over-year to 68.41%; the TTM value through Dec 2025 reached 67.41%, up 851.0%, while the annual FY2025 figure was 67.41%, 851.0% up from the prior year.
  • Gross Margin reached 68.41% in Q4 2025 per GMED's latest filing, up from 67.16% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 75.8% in Q1 2021 to a low of 56.77% in Q3 2024.
  • Average Gross Margin over 5 years is 68.6%, with a median of 71.09% recorded in 2023.
  • Peak YoY movement for Gross Margin: plummeted -1734bps in 2023, then soared 1040bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 75.28% in 2021, then decreased by -1bps to 74.28% in 2022, then dropped by -23bps to 56.94% in 2023, then grew by 5bps to 59.92% in 2024, then rose by 14bps to 68.41% in 2025.
  • Per Business Quant, the three most recent readings for GMED's Gross Margin are 68.41% (Q4 2025), 67.16% (Q3 2025), and 66.62% (Q2 2025).